Biolevate raised €30M in a Series A round in Sep 2026. The company is based in Paris, France. Investors in the round: EQT Ventures, MSD Global Health Innovation Fund (MGHIF), Orange Ventures and 2 others. Data as of 23 Sept 2026.
Reported in EUR — no conversion. €30M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
